Maarten te Groen
@mtegroen.bsky.social
Resident in Gastroenterology @Radboud University Medical Center | former UEG Young Talent Group member | Science!
Reposted by Maarten te Groen
🚀 Are you passionate about shaping the future of gastroenterology? Join UEG’s Young Talent Group!
Learn more and apply by March 13: https://bit.ly/3p0zyJo
#myUEGcommunity #weareUEG
Learn more and apply by March 13: https://bit.ly/3p0zyJo
#myUEGcommunity #weareUEG
February 18, 2025 at 10:01 AM
🚀 Are you passionate about shaping the future of gastroenterology? Join UEG’s Young Talent Group!
Learn more and apply by March 13: https://bit.ly/3p0zyJo
#myUEGcommunity #weareUEG
Learn more and apply by March 13: https://bit.ly/3p0zyJo
#myUEGcommunity #weareUEG
Our💡#HELIOS trial on colorectal neoplasia surveillance in #IBD is published @Gut_BMJ
✅HD White-light endoscopy with segmental re-inspection is non-inferior to Chromoendoscopy
✅No difference in CRN detection per 10min withdrawal time
gut.bmj.com/content/earl...
✅HD White-light endoscopy with segmental re-inspection is non-inferior to Chromoendoscopy
✅No difference in CRN detection per 10min withdrawal time
gut.bmj.com/content/earl...
Surveillance in inflammatory bowel disease: white light endoscopy with segmental re-inspection versus dye-based chromoendoscopy – a multi-arm randomised controlled trial (HELIOS)
Background It remains unclear if the increased colorectal neoplasia detection rate in inflammatory bowel disease (IBD) by high-definition (HD) dye-based chromoendoscopy compared with HD white-light en...
gut.bmj.com
February 1, 2025 at 8:49 AM
Our💡#HELIOS trial on colorectal neoplasia surveillance in #IBD is published @Gut_BMJ
✅HD White-light endoscopy with segmental re-inspection is non-inferior to Chromoendoscopy
✅No difference in CRN detection per 10min withdrawal time
gut.bmj.com/content/earl...
✅HD White-light endoscopy with segmental re-inspection is non-inferior to Chromoendoscopy
✅No difference in CRN detection per 10min withdrawal time
gut.bmj.com/content/earl...
Reposted by Maarten te Groen
HELIOS trial (neoplasia detection in IBD)
- high-def segmental re-inspection is not inferior to high-def chromoendoscopy (10.3% vs 13.1%, non-inferiority margin of 10%)
- 'benefit' of chromoendoscopy might be due to withdrawal/inspection time
- overall neoplasia rate was low (10.5%)
#IBDSky
- high-def segmental re-inspection is not inferior to high-def chromoendoscopy (10.3% vs 13.1%, non-inferiority margin of 10%)
- 'benefit' of chromoendoscopy might be due to withdrawal/inspection time
- overall neoplasia rate was low (10.5%)
#IBDSky
January 18, 2025 at 5:41 AM
HELIOS trial (neoplasia detection in IBD)
- high-def segmental re-inspection is not inferior to high-def chromoendoscopy (10.3% vs 13.1%, non-inferiority margin of 10%)
- 'benefit' of chromoendoscopy might be due to withdrawal/inspection time
- overall neoplasia rate was low (10.5%)
#IBDSky
- high-def segmental re-inspection is not inferior to high-def chromoendoscopy (10.3% vs 13.1%, non-inferiority margin of 10%)
- 'benefit' of chromoendoscopy might be due to withdrawal/inspection time
- overall neoplasia rate was low (10.5%)
#IBDSky